CH353743A - Method for preparing piperazines - Google Patents
Method for preparing piperazinesInfo
- Publication number
- CH353743A CH353743A CH353743DA CH353743A CH 353743 A CH353743 A CH 353743A CH 353743D A CH353743D A CH 353743DA CH 353743 A CH353743 A CH 353743A
- Authority
- CH
- Switzerland
- Prior art keywords
- piperazines
- allyl alcohol
- formula
- preparing
- piperazine
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 150000004885 piperazines Chemical class 0.000 title claims description 6
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- -1 alkyl radical Chemical class 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 claims description 2
- 150000003254 radicals Chemical class 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- WICKLEOONJPMEQ-UHFFFAOYSA-N 1-(2-methylphenyl)piperazine Chemical compound CC1=CC=CC=C1N1CCNCC1 WICKLEOONJPMEQ-UHFFFAOYSA-N 0.000 description 1
- RXJURXTXLCOIDY-UHFFFAOYSA-N 1-(2-methylsulfanylphenyl)piperazine Chemical compound CSC1=CC=CC=C1N1CCNCC1 RXJURXTXLCOIDY-UHFFFAOYSA-N 0.000 description 1
- PFABEHNQMBYJGF-UHFFFAOYSA-N 3-[4-(2-ethoxyphenyl)piperazin-1-yl]propan-1-ol Chemical group CCOC1=CC=CC=C1N1CCN(CCCO)CC1 PFABEHNQMBYJGF-UHFFFAOYSA-N 0.000 description 1
- XLORWOVJUOSFND-UHFFFAOYSA-N 3-[4-(2-methylphenyl)piperazin-1-yl]propan-1-ol Chemical group CC1=CC=CC=C1N1CCN(CCCO)CC1 XLORWOVJUOSFND-UHFFFAOYSA-N 0.000 description 1
- LWEOFVINMVZGAS-UHFFFAOYSA-N 3-piperazin-1-ylpropan-1-ol Chemical class OCCCN1CCNCC1 LWEOFVINMVZGAS-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Procédé de préparation de pipérazines
L'invention a pour objet un procédé de préparation de pipérazines de formule
EMI1.1
dans laquelle Q désigne un radical alcoyle inférieur ou un radical -O-R ou -S -R, R représentant un radical alcoyle inférieur ou un radical allyle. Ces composés peuvent être transformés en sels d'addition d'acide par réaction avec des acides minéraux tels que les acides chlorhydrique, bromhydrique, sulfurique, phosphorique, iodhydrique et semblables.
Le procédé selon l'invention est caractérisé en ce que l'on fait réagir une N-phényl-pipérazine de formule:
EMI1.2
avec de l'alcool allylique en présence d'un alcoolate de métal alcalin de l'alcool allylique. La température de réaction n'est pas critique et peut t varier entre de larges limites. Des températures comprises entre 75 et 1500 C, ou parfois entre 75 et 1000 C, conviennent, en particulier les températures de reflux. Pour obtenir les meilleurs résultats, la réaction est en général effectuée en l'absence de tout solvant autre que l'alcool allylique. Les pipérazinepropanols obtenus par ce procédé peuvent être convertis en les esters correspondants par acylation.
Les sels d'addition d'acide des pipérazines obtenues selon le procédé de l'invention peuvent être préparés en faisant réagir la base libre avec un acide en présence d'un solvant organique convenable dans lequel le sel résultant est insoluble, ce qui permet d'isoler le sel désiré par filtration, décantation, etc.
D'autre part, dans les cas où il est désiré de convertir le sel par addition d'acide en la base libre, cela peut être effectué en dissolvant ce sel dans un solvant convenable, tel que l'eau, le méthanol, etc., neutralisant la solution avec une base telle que l'hydroxyde de sodium, l'hydroxyde d'ammonium, un carbonate de métal alcalin, etc., et en isolant la base libre désirée par extraction ou autre moyen convenable.
Les pipérazines résultant du procédé selon l'invention et leurs sels d'acides possèdent une activité pharmacologique, et peuvent être utilisés, administrés sous une forme à dosage convenable, pour la prévention de nausées et de vomissements, ainsi que pour le traitement de l'hypertension et d'états d'anxiété.
Ces substances présentent aussi de l'intérêt comme produits intermédiaires pour la préparation d'autres substances chimiques.
Exemple 1
35,2 g de 1 -(o-méthyl-phényl)-pipérazine, sont ajoutés à une solution de 5 g de sodium métallique et 130 ml d'alcool allylique, et chauffés avec reflux pendant 80 heures, tout en agitant. Le mélange de réaction est refroidi, dilué avec 250 ml d'eau, puis on enlève sensiblement tout l'alcool allylique par distillation dans le vide. Le résidu est extrait avec du benzène et la solution benzénique est traitée avec du charbon activé, puis filtrée. Le filtrat est concentré jusqu'à environ 75 ml puis dilué avec trois volumes d'éther de pétrole à bas point d'ébullition. La substance brute qui cristallise par refroidissement est recristallisée dans un mélange de benzène et d'éther de pétrole à bas point d'ébullition.
Ce produit est le 4-(o-méthyl-phényl)-pipérazine- 1 -propanol; P. F. 99- 1010 C. Sa formule est:
EMI2.1
Son sel d'acide sulfurique est obtenu en dissolvant la base ci-dessus dans de l'éthanol contenant une quantité équimoléculaire d'acide sulfurique, en recueillant le précipité formé par filtration et le recristallisant dans de l'isopropanol. Sa formule est:
EMI2.2
Exemple 2
A une solution de 5 g de sodium métallique et 130 ml d'alcool allylique, on ajoute 41,2 g de l-(oéthoxy-phényl)-pipérazine et chauffe avec reflux pendant 80 heures tout en agitant. Le mélange de réaction est alors refroidi, dilué avec 250 ml d'eau, puis l'alcool allylique est enlevé par distillation dans le vide.
Le résidu est extrait avec du benzène, l'extrait au benzène est traité avec 2 o/o de charbon activé, puis filtré, et les solvants sont éliminés sous pression réduite. Le produit résiduaire est le 4-(o-éthoxy- phényl) -l -pipérazine-propanol. Son sel d'acide sulfurique est obtenu en dissolvant ce produit dans de l'éthanol contenant une quantité équimoléculaire d'acide sulfurique et recueillant le précipité formé par filtration et le recristallisant dans de l'isopropanol.
Le produit formé par addition d'acide sulfurique a la formule:
EMI2.3
Exemple 3
Un mélange de 41,6 g de l-(o-méthylmercaptophényl)-pipérazine, 5 g de sodium métallique et 130 ml d'alcool allylique est chauffé avec reflux tout en l'agitant pendant 80 heures. Le mélange de réaction est refroidi, dilué avec 250 ml d'eau, puis sensiblement tout l'alcool allylique est éliminé par distillation dans le vide. Le résidu est extrait avec du benzène, la solution benzénique est traitée avec environ 2 O/o de charbon activé, puis filtrée, et les solvants sont éliminés des filtrats par distillation sous pression réduite.
Le produit résiduaire, le 4-(o méthylmercapto-phényl)-l-pipérazine-propanol a la formule:
EMI2.4
Le sel d'acide sulfurique est obtenu en dissolvant la base libre ci-dessus dans de l'méthanol contenant une quantité équimoléculaire d'acide sulfurique et retirant le précipité formé par filtration et le recristallisant dans de l'isopropanol. Sa formule est:
EMI2.5
Method for preparing piperazines
The subject of the invention is a process for preparing piperazines of formula
EMI1.1
in which Q denotes a lower alkyl radical or an -O-R or -S -R radical, R representing a lower alkyl radical or an allyl radical. These compounds can be converted to acid addition salts by reaction with mineral acids such as hydrochloric, hydrobromic, sulfuric, phosphoric, hydroiodic and the like.
The process according to the invention is characterized in that an N-phenyl-piperazine of formula is reacted:
EMI1.2
with allyl alcohol in the presence of an alkali metal alcoholate of allyl alcohol. The reaction temperature is not critical and can vary between wide limits. Temperatures between 75 and 1500 C, or sometimes between 75 and 1000 C, are suitable, in particular reflux temperatures. For best results, the reaction is generally carried out in the absence of any solvent other than allyl alcohol. The piperazinepropanols obtained by this process can be converted to the corresponding esters by acylation.
The acid addition salts of the piperazines obtained according to the process of the invention can be prepared by reacting the free base with an acid in the presence of a suitable organic solvent in which the resulting salt is insoluble, which allows to '' isolate the desired salt by filtration, decantation, etc.
On the other hand, in cases where it is desired to convert the salt by adding acid to the free base, this can be done by dissolving this salt in a suitable solvent, such as water, methanol, etc. , neutralizing the solution with a base such as sodium hydroxide, ammonium hydroxide, alkali metal carbonate, etc., and isolating the desired free base by extraction or other suitable means.
The piperazines resulting from the process according to the invention and their acid salts possess pharmacological activity, and can be used, administered in a suitable dosage form, for the prevention of nausea and vomiting, as well as for the treatment of. hypertension and anxiety states.
These substances are also of interest as intermediates for the preparation of other chemicals.
Example 1
35.2 g of 1 - (o-methyl-phenyl) -piperazine are added to a solution of 5 g of metallic sodium and 130 ml of allyl alcohol, and heated with reflux for 80 hours, while stirring. The reaction mixture is cooled, diluted with 250 ml of water, then substantially all of the allyl alcohol is removed by vacuum distillation. The residue is extracted with benzene and the benzene solution is treated with activated charcoal, then filtered. The filtrate is concentrated to approximately 75 ml then diluted with three volumes of low boiling petroleum ether. The crude substance which crystallizes on cooling is recrystallized from a mixture of benzene and low boiling petroleum ether.
This product is 4- (o-methyl-phenyl) -piperazine-1 -propanol; P. F. 99-1010 C. Its formula is:
EMI2.1
Its sulfuric acid salt is obtained by dissolving the above base in ethanol containing an equimolecular amount of sulfuric acid, collecting the precipitate formed by filtration and recrystallizing it from isopropanol. Its formula is:
EMI2.2
Example 2
To a solution of 5 g of metallic sodium and 130 ml of allyl alcohol, 41.2 g of 1- (oethoxy-phenyl) -piperazine are added and refluxed for 80 hours while stirring. The reaction mixture is then cooled, diluted with 250 ml of water, then the allyl alcohol is removed by vacuum distillation.
The residue is extracted with benzene, the benzene extract is treated with 2% activated charcoal, then filtered, and the solvents are removed under reduced pressure. The waste product is 4- (o-ethoxyphenyl) -1 -piperazine-propanol. Its sulfuric acid salt is obtained by dissolving this product in ethanol containing an equimolecular quantity of sulfuric acid and collecting the precipitate formed by filtration and recrystallizing it in isopropanol.
The product formed by adding sulfuric acid has the formula:
EMI2.3
Example 3
A mixture of 41.6 g of 1- (o-methylmercaptophenyl) -piperazine, 5 g of metallic sodium and 130 ml of allyl alcohol is heated with reflux while stirring for 80 hours. The reaction mixture is cooled, diluted with 250 ml of water, then substantially all of the allyl alcohol is removed by vacuum distillation. The residue is extracted with benzene, the benzene solution is treated with approximately 2 O / o of activated charcoal, then filtered, and the solvents are removed from the filtrates by distillation under reduced pressure.
The waste product, 4- (o methylmercapto-phenyl) -1-piperazine-propanol has the formula:
EMI2.4
The sulfuric acid salt is obtained by dissolving the above free base in methanol containing an equimolecular quantity of sulfuric acid and removing the precipitate formed by filtration and recrystallizing it from isopropanol. Its formula is:
EMI2.5
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US353743XA | 1955-06-29 | 1955-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH353743A true CH353743A (en) | 1961-04-30 |
Family
ID=21882286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH353743D CH353743A (en) | 1955-06-29 | 1956-06-29 | Method for preparing piperazines |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH353743A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459797A2 (en) * | 1978-08-01 | 1981-01-16 | Synthelabo | PHENYL-1 PIPERAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION |
-
1956
- 1956-06-29 CH CH353743D patent/CH353743A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459797A2 (en) * | 1978-08-01 | 1981-01-16 | Synthelabo | PHENYL-1 PIPERAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH375017A (en) | Process for the preparation of novel imidazole derivatives | |
| CH353743A (en) | Method for preparing piperazines | |
| CH354085A (en) | Method for preparing piperazines | |
| BE642084A (en) | ||
| CH354084A (en) | Method for preparing piperazines | |
| CH624089A5 (en) | ||
| CH354086A (en) | Method for preparing piperazines | |
| CH354087A (en) | Method for preparing piperazines | |
| CH350296A (en) | Process for the preparation of N- (o-halo-phenyl) -piperazines N'-alkylated | |
| EP0148666B1 (en) | Process for preparing hydroxy-3-methyl-3 glutaric acid | |
| BE524609A (en) | ||
| CH365381A (en) | Process for the preparation of piperazine derivatives | |
| CA1099718A (en) | Process for the preparation of novel napthalene derivatives | |
| CH363349A (en) | Method for preparing piperazines | |
| BE530797A (en) | ||
| BE633582A (en) | ||
| CH315583A (en) | Process for preparing unsaturated lactones | |
| BE488507A (en) | ||
| CH268051A (en) | Process for preparing 1-methyl-4-piperazine-N, N-diethyl-carboxamide. | |
| BE523903A (en) | ||
| CH298775A (en) | Process for preparing an antihistamine substance. | |
| CH501595A (en) | 2-phenoxy-2-phenylacetamides | |
| BE530796A (en) | ||
| BE493470A (en) | ||
| CH420107A (en) | Process for the preparation of new substituted aralkylaminoalkylcyclohexane derivatives |